NCI Awards Labcyte $1M to Develop Mass Spec-based Cancer Biomarker Detection Method | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Labcyte $1 million to create a process for detecting cancer-associated proteins in samples, the company announced today.

The initial work will be directed at breast cancer and includes researchers from the Canary Center at Stanford University and the Fred Hutchinson Cancer Research Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.